المؤلفون: Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW

مؤلفون مشاركون: Diabetic Retinopathy Clinical Research Network

المصدر: The New England journal of medicine [N Engl J Med] 2015 Mar 26; Vol. 372 (13), pp. 1193-203. Date of Electronic Publication: 2015 Feb 18.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Diabetic Retinopathy/*drug therapy , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Vascular Endothelial Growth Factor A/*antagonists & inhibitors , Visual Acuity/*drug effects, Adult ; Aged ; Angiogenesis Inhibitors/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Bevacizumab ; Double-Blind Method ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Ranibizumab ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Retina/drug effects ; Retina/pathology ; Therapeutic Equivalency